How big is the Biosimilars Market ?
Global Biosimilars Market reached USD 30.1 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 76.7 billion by 2031.
Who are the key players in Biosimilars Market ?
Major players are Amgen Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Biocon, Samsung Bioepis, Mylan NV, Celltrion, Biogen and Intas Pharmaceutical Ltd.